iRhythm Technologies Inc
IRTC188.300USD
+5.090+2.78%
Close 11/25, 16:00（ET）Quotes delayed by 15 min
6.06BMarket Cap
LossP/E TTM
More Details of iRhythm Technologies Inc Company
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
iRhythm Technologies Inc Info
Ticker SymbolIRTC
Company nameiRhythm Technologies Inc
IPO dateOct 20, 2016
CEOMr. Quentin S. Blackford
Number of employees2000
Security typeOrdinary Share
Fiscal year-endOct 20
Address699 8th Street
CitySAN FRANCISCO
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code94103
Phone14156325700
Websitehttps://www.irhythmtech.com/
Ticker SymbolIRTC
IPO dateOct 20, 2016
CEOMr. Quentin S. Blackford
Company Executives of iRhythm Technologies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.30K
-18.17%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
33.78K
-1.90%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
18.46K
--
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
15.84K
-3.74%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
12.56K
-10.16%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+13.46%
Mr. Bruce G. Bodaken
Mr. Bruce G. Bodaken
Independent Director
Independent Director
10.80K
+14.39%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
7.73K
+21.32%
Mr. Daniel G. (Dan) Wilson
Mr. Daniel G. (Dan) Wilson
Chief Financial Officer
Chief Financial Officer
3.96K
-66.88%
Ms. Karen K. Mcginnis, CPA
Ms. Karen K. Mcginnis, CPA
Independent Director
Independent Director
2.04K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.30K
-18.17%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
33.78K
-1.90%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
18.46K
--
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
15.84K
-3.74%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
12.56K
-10.16%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+13.46%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Commercial Payors
97.72M
52.34%
Contracted third-party payors
97.72M
52.34%
Centers for Medicare & Medicaid
44.48M
23.83%
Healthcare Institutions
31.83M
17.05%
Non-contracted third-party payors
12.66M
6.78%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Commercial Payors
97.72M
52.34%
Contracted third-party payors
97.72M
52.34%
Centers for Medicare & Medicaid
44.48M
23.83%
Healthcare Institutions
31.83M
17.05%
Non-contracted third-party payors
12.66M
6.78%
Shareholding Stats
Updated: Tue, Nov 18
Updated: Tue, Nov 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.03%
Artisan Partners Limited Partnership
7.97%
BlackRock Institutional Trust Company, N.A.
7.35%
Sands Capital Management, LLC
6.94%
Capital Research Global Investors
3.67%
Other
64.04%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.03%
Artisan Partners Limited Partnership
7.97%
BlackRock Institutional Trust Company, N.A.
7.35%
Sands Capital Management, LLC
6.94%
Capital Research Global Investors
3.67%
Other
64.04%
Shareholder Types
Shareholders
Proportion
Investment Advisor
66.24%
Investment Advisor/Hedge Fund
28.39%
Hedge Fund
10.19%
Research Firm
5.20%
Family Office
1.35%
Individual Investor
1.02%
Pension Fund
0.97%
Sovereign Wealth Fund
0.71%
Bank and Trust
0.54%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
609
36.08M
112.00%
-5.27M
2025Q2
586
36.46M
113.50%
-2.59M
2025Q1
586
36.68M
114.94%
-2.13M
2024Q4
571
35.12M
111.82%
-4.41M
2024Q3
584
35.86M
114.62%
-4.91M
2024Q2
581
36.60M
117.28%
-2.20M
2024Q1
578
35.68M
114.75%
-1.24M
2023Q4
542
34.05M
110.03%
-1.99M
2023Q3
543
34.13M
111.64%
-2.86M
2023Q2
537
34.27M
112.49%
-3.29M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
3.23M
10.05%
+127.22K
+4.10%
Jun 30, 2025
Artisan Partners Limited Partnership
2.74M
8.53%
-73.44K
-2.61%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.33M
7.25%
-18.29K
-0.78%
Jun 30, 2025
Sands Capital Management, LLC
2.92M
9.07%
-100.68K
-3.34%
Jun 30, 2025
Capital Research Global Investors
1.51M
4.69%
-695.76K
-31.59%
Jun 30, 2025
Capital World Investors
1.44M
4.47%
+247.00
+0.02%
Aug 31, 2025
State Street Investment Management (US)
868.52K
2.7%
-49.16K
-5.36%
Jun 30, 2025
Geode Capital Management, L.L.C.
767.34K
2.39%
+16.97K
+2.26%
Jun 30, 2025
William Blair & Company, L.L.C. (Research)
739.33K
2.3%
-50.67K
-6.41%
Jun 30, 2025
Eventide Asset Management, LLC
691.57K
2.15%
-48.49K
-6.55%
Jun 30, 2025
View more
Related ETFs
Updated: Sun, Nov 2
Updated: Sun, Nov 2
Name
Proportion
Global X HealthTech ETF
4.9%
Fidelity Digital Health ETF
2.4%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.9%
Invesco Dorsey Wright Healthcare Momentum ETF
1.72%
ROBO Global Healthcare Technology & Innovation ETF
1.56%
SPDR S&P Health Care Equipment ETF
1.55%
Langar Global HealthTech ETF
1.52%
Goldman Sachs Future Health Care Equity ETF
1.49%
First Trust Multi-Manager Small Cap Opportunities ETF
1.13%
Inspire Fidelis Multi Factor ETF
1.03%
View more
Global X HealthTech ETF
Proportion4.9%
Fidelity Digital Health ETF
Proportion2.4%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion1.9%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion1.72%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.56%
SPDR S&P Health Care Equipment ETF
Proportion1.55%
Langar Global HealthTech ETF
Proportion1.52%
Goldman Sachs Future Health Care Equity ETF
Proportion1.49%
First Trust Multi-Manager Small Cap Opportunities ETF
Proportion1.13%
Inspire Fidelis Multi Factor ETF
Proportion1.03%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of iRhythm Technologies Inc?
The top five shareholders of iRhythm Technologies Inc are:
The Vanguard Group, Inc. holds 3.23M shares, accounting for 10.05% of the total shares.
Artisan Partners Limited Partnership holds 2.74M shares, accounting for 8.53% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.33M shares, accounting for 7.25% of the total shares.
Sands Capital Management, LLC holds 2.92M shares, accounting for 9.07% of the total shares.
Capital Research Global Investors holds 1.51M shares, accounting for 4.69% of the total shares.
The Vanguard Group, Inc. holds 3.23M shares, accounting for 10.05% of the total shares.
Artisan Partners Limited Partnership holds 2.74M shares, accounting for 8.53% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.33M shares, accounting for 7.25% of the total shares.
Sands Capital Management, LLC holds 2.92M shares, accounting for 9.07% of the total shares.
Capital Research Global Investors holds 1.51M shares, accounting for 4.69% of the total shares.
What are the top three shareholder types of iRhythm Technologies Inc?
The top three shareholder types of iRhythm Technologies Inc are:
The Vanguard Group, Inc.
Artisan Partners Limited Partnership
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Artisan Partners Limited Partnership
BlackRock Institutional Trust Company, N.A.
How many institutions hold shares of iRhythm Technologies Inc (IRTC)?
As of 2025Q3, 609 institutions hold shares of iRhythm Technologies Inc, with a combined market value of approximately 36.08M, accounting for 112.00% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -1.50%.
What is the biggest source of revenue for iRhythm Technologies Inc?
In FY2025Q2, the Commercial Payors business generated the highest revenue for iRhythm Technologies Inc, amounting to 97.72M and accounting for 52.34% of total revenue.
